SLN
Silence Therapeutics PLC
9.80$
-0.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | -97.9% | +0.0% | – | – | – | – | – | – | – | – | – | +0.0% | +369.7% | +0.0% | +246.9% | +18.0% | +34.1% | -14.1% | +16.8% | +8.2% | +67.6% | -36.3% | -7.5% | +41.4% | +138.7% | -20.0% | -69.3% | -25.0% | +647.9% | -96.2% | +91.0% | +2,030.3% | -99.2% | +67.2% | -48.2% | -78.6% | +1,139.1% | -100.0% | – | |
| – | +0.0% | -5.5% | +0.0% | +8.1% | +0.0% | +26.3% | +0.0% | -13.1% | +0.0% | +11.5% | +0.0% | +0.0% | +0.0% | – | – | -54.2% | -38.6% | +7.4% | +18.7% | +12.4% | -0.5% | +11.4% | +3.4% | +1.8% | +61.2% | +17.5% | -37.6% | -43.2% | -16.2% | +108.0% | -5.8% | +5.2% | -42.1% | -95.7% | +66.9% | -45.1% | -81.3% | +873.4% | -7.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | -159.9% | – | +75.8% | -45.5% | +26.0% | +24.3% | +151.2% | -62.5% | -24.3% | -7.3% | +655.0% | -8.3% | -81.0% | -36.8% | +1,613.0% | -115.8% | – | – | -99.5% | +67.4% | -50.2% | -76.8% | +1,284.0% | -135.5% | – | |
| – | +0.0% | -5.5% | +0.0% | +8.1% | +0.0% | +26.3% | +0.0% | -13.1% | +0.0% | +11.5% | +0.0% | +63.9% | +0.0% | +22.9% | +0.0% | -31.9% | +198.8% | -28.0% | +9.5% | -3.1% | -8.7% | +5.2% | +42.5% | -19.0% | -4.2% | +49.3% | +0.6% | -29.2% | +11.2% | +19.2% | -7.2% | +39.2% | +33.3% | +32.0% | -10.1% | -15.1% | -57.4% | -4.6% | -0.4% | – | |
| – | +0.0% | +57.5% | +0.0% | +14.0% | +0.0% | +36.0% | +0.0% | +31.3% | +0.0% | -24.3% | +0.0% | +7.2% | +0.0% | +3.4% | +0.0% | +3.3% | +130.9% | -39.1% | +43.4% | +1.8% | -1.1% | +6.6% | -21.1% | +28.1% | -40.5% | +86.0% | -20.7% | -3.1% | -17.0% | +61.2% | -20.3% | +5.9% | -3.7% | +84.3% | -29.2% | -17.6% | -35.6% | +88.2% | -33.2% | – | |
| – | +0.0% | -8.5% | +0.0% | -110.0% | – | – | +0.0% | +39.5% | +0.0% | -26.2% | +0.0% | +76.5% | +0.0% | +86.7% | +0.0% | +20.3% | +40.9% | -15.8% | +26.1% | -3.0% | -5.6% | +5.8% | +15.0% | -5.1% | -18.7% | +60.0% | -6.6% | -21.7% | +1.2% | +31.5% | -11.9% | +28.4% | +23.4% | +42.9% | -10.3% | -20.3% | -52.6% | +22.8% | -15.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | +346.2% | -58.8% | -70.8% | +21.9% | +348.7% | +91.1% | -94.9% | -61.8% | +6,515.4% | +3.8% | -99.1% | +11,500.0% | -98.6% | +1,307.7% | +4,600.5% | +34.2% | +0.0% | – | – | – | – | – | – | |
| – | – | – | – | – | +0.0% | -439.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -255.5% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | -140.2% | – | -298.1% | – | – | – | – | – | – | – | – | – | – | – | – | -870.1% | – | – | +0.0% | -99.9% | -92.7% | -200.0% | – | – | – | |
| – | – | – | – | – | +0.0% | -322.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -360.4% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -610.7% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.